Citation Impact
Citing Papers
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
2012
Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
2009
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases
2020
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Immune Response in Hepatitis B Virus Infection
2015
The three human monocyte subsets: implications for health and disease
2012
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
2019
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology
2016
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
T cell exhaustion
2011 Standout
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
2019
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Acute-on chronic liver failure
2012
Prediction of the prognosis in patients with acute‐on‐chronic hepatitis using the MELD scoring system
2006
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Hepatitis B cure: From discovery to regulatory approval
2017
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
2010
Viral acute lower respiratory infections impair CD8+ T cells through PD-1
2012
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Acute-on-chronic liver failure: terminology, mechanisms and management
2016
Natural killer cells in liver disease
2012
Living in the liver: hepatic infections
2012
Progressive CD127 down‐regulation correlates with increased apoptosis of CD8 T cells during chronic HIV‐1 infection
2009
Preliminary predictive criteria for COVID-19 cytokine storm
2020
The PD‐1 pathway in tolerance and autoimmunity
2010 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Global burden of liver disease: 2023 update
2023 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
2015
A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection
2016
The role of innate immunity in the immunopathology and treatment of HBV infection
2016
The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses
2009
Adaptive immunity in HBV infection
2016
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
2014
Clonal Exhaustion as a Mechanism to Protect Against Severe Immunopathology and Death from an Overwhelming CD8 T Cell Response
2013
Reassessment of Exosome Composition
2019 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
2016
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
2014
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
2013
The role of extracellular vesicles in COVID-19 virus infection
2020
Increased Th17 cells contribute to disease progression in patients with HBV‐associated liver cirrhosis
2012
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
2009
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
2014
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2013
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Cytokine Storm
2020 Standout
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Dexamethasone in outcome of patients with hepatitis B virus‐related acute‐on‐chronic liver failure
2013
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Innate immunity in alcoholic liver disease
2011
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
2018
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of Baosen Li being referenced
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients
2010
Imbalanced Intrahepatic Cytokine Expression of Interferon-γ, Tumor Necrosis Factor-α, and Interleukin-10 in Patients With Acute-on-Chronic Liver Failure Associated With Hepatitis B Virus Infection
2009
Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience
2020
Dynamic Programmed Death 1 Expression by Virus-Specific CD8 T Cells Correlates With the Outcome of Acute Hepatitis B
2008
Hyper-Activated Pro-Inflammatory CD16+ Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B
2011
Compartmentalization and its implication for peripheral immunologically‐competent cells to the liver in patients with HBV‐related acute‐on‐chronic liver failure
2009
Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013
2017
Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection
2014
Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013
2017
A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis
2013
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis
2014
[Single factor study of prognosis from 520 cases with chronic severe hepatitis].
2002